orphan drug status News
Most Popular orphan drug status Story
BioMarin perfects the popular rare disease drug model
One of the big trends in drug development over the past three years has been the growing popularity of new treatments for rare diseases. And if you read through Bloomberg's lengthy feature on Novato, Read more...
Latest Headlines
- January 23, 2012
- December 15, 2011
- November 18, 2011
- October 12, 2011
- March 10, 2010
- November 4, 2009
- September 16, 2009
- January 21, 2009
- May 9, 2008
- February 22, 2008
- January 28, 2008
- December 20, 2007
- November 27, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
